Stock VYNE VYNE THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2025-01-22 pm EST 		5-day change 1st Jan Change
2.720 USD -1.81% Intraday chart for VYNE Therapeutics Inc. -1.45% -18.81%
Jan. 06 VYNE Therapeutics Completes Enrollment in Phase 2B Trial Evaluating Vyn201 for the Treatment of Nonsegmental Vitiligo CI
Dec. 23 VYNE Therapeutics Reports 'Positive' Phase 1a Results for VYN202 Inhibitor MT
ac5aaf064eb97ef.zgT22RAhmIHTQkMqRbNOfT_V8LwYlTDLasRTY-VIW1Y.gUiv62dFqMqVM3thc9g_Ewig3fct1ED8WPdlVpwRHDWPNsW-XlfvsuEhBg~61c4b7834a24a28fbbafc3478b9e097d
  1. Stock Market
  2. Equities
  3. VYNE Stock
  4. Charts VYNE Therapeutics Inc.
  5. News Chart